Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 4

Abstract

ABSTRACT Pulmonary Alveolar Proteinosis (PAP) is a rare disorder characterised by accumulation of surfactant in alveoli due to impaired surfactant clearance. Although, whole lung lavage is the standard treatment of PAP, rituximab has also been introduced as a therapeutic option for PAP. A 49-year-old female patient, a known case of PAP, came to the outpatient clinic complaining of exacerbation of dyspnoea. The patient was treated with rituximab four times in a year. Finally, the clinical status and spirometry tests showed improvement. Although, the main treatment for PAP is whole lung lavage, other therapeutic options may be useful too. According to the prior case reports and the present one, rituximab can be useful in treatment of PAP.

Authors and Affiliations

Fatemeh Aghaei Meybodi, Salar Khazani Fard, Mojtaba Babaei Zarch, Mostafa Babai

Keywords

Related Articles

Medical Education System in South Asia and its Consequences on our Health: A Review

South Asia is home to nearly one-quarter of the world's population, making it the most densely populated geographical region in the world plagued with high rates of communicable and non-communicable diseases, maternal an...

Healthcare Associated Infection in Paediatric Intensive Care Unit-A Tertiary Care Hospital Experience

ABSTRACT Introduction: Healthcare Associated Infections (HAI) are those that are acquired in a health care setting or one that is acquired in the hospital environment by a patient who had been admitted to the hospital f...

Benefits of Alcohol on Arsenic Toxicity in Rats

Introduction: It has been demonstrated earlier that exposure to ethanol and/or arsenic compounds (such as sodium arsenite) produces toxic effects as shown by both in vitro and in vivo experiments. Chronic exposure of hum...

Short Course Hypofractionated Radiotherapy versus Conventional Radiotherapy for Poor Prognosis Glioblastoma Multiforme: A Randomised Controlled Trial

ABSTRACT Introduction: Glioblastoma Multiforme (GBM) has a variegated outcome due to several prognostic factors, radiotherapy dose being one of them. Aim: To find whether short course hypofractionated Radiotherapy (RT) i...

Childhood Onset Nephrotic Syndrome-A Journey Through Two Pregnancies

Nephrotic Syndrome (NS), a unique renal disease complex associated with heavy proteinuria (protein excretion >3.5 gm/day), hypoalbuminemia (<30 gm/L) and peripheral oedema. It is a rare entity in pregnancy, with an incid...

Download PDF file
  • EP ID EP523032
  • DOI 10.7860/JCDR/2018/32371.11419
  • Views 79
  • Downloads 0

How To Cite

Fatemeh Aghaei Meybodi, Salar Khazani Fard, Mojtaba Babaei Zarch, Mostafa Babai (2018). Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report. Journal of Clinical and Diagnostic Research, 12(4), 7-8. https://europub.co.uk/articles/-A-523032